The forecasted trend for anaemia prevalence among non-pregnant women in France shows a gradual increase from 19.43% in 2024 to 20.31% by 2028. This progression indicates a consistent annual growth in the prevalence rate. From 2023 to 2024, the year-on-year variation is minimal, suggesting a steady rise rather than abrupt increases. The compound annual growth rate (CAGR) over this five-year forecast period also underscores a persistent yet moderate ascent in prevalence.
Future trends to watch for include potential impacts from public health interventions aimed at reducing anaemia through improved nutrition and healthcare access, alongside monitoring socio-economic factors that may influence these rates.
